RNA Connect
1 known investors
RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.
Founders & leadership
Investors · 1
Competitors · 3
by search overlap
IDbyDNA26 shared keywordsScalable, high throughput DNA sequencing platforms.
Oup18 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Nanoporetech15 shared keywordsOxford Nanopore offers educational programs and tools to make DNA sequencing accessible to students and educators from high school through undergraduate levels. The company works with institutions and scientific educators to integrate nanopore sequencing technology into classroom settings and address the world's pressing challenges.
Companies competing with RNA Connect for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does RNA Connect do?
- RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.
- Who founded RNA Connect?
- RNA Connect was founded by Anna Pyle, Li-Tao Guo.
- Who are RNA Connect's investors?
- RNA Connect's investors include Connecticut Innovations.